These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 26447199

  • 1. Prolonged Infusions of Low-Dose Thrombolytics in Elderly Patients With Prosthetic Heart Valve Thrombosis.
    Gündüz S, Özkan M, Yesin M, Kalçık M, Gürsoy MO, Karakoyun S, Astarcıoğlu MA, Aykan AÇ, Gökdeniz T, Biteker M, Duran NE, Yıldız M.
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):241-247. PubMed ID: 26447199
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
    Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, Aykan AÇ, Çakal B, Bayram Z, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T, Duran NE, Yıldız M, Esen AM.
    Am Heart J; 2015 Aug; 170(2):409-18. PubMed ID: 26299240
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis.
    Kathirvel D, Justin Paul G, Prathap Kumar G, Palanisamy G, Gnanavelu G, Ravishankar G, Swaminathan N, Venkatesan S.
    Indian Heart J; 2018 Aug; 70(4):506-510. PubMed ID: 30170645
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Successful fibrinolytic treatment of prosthetic heart valve thrombosis using streptokinase.
    Sakr SA, Abdel-Shakour H, Ramadan MM.
    Acta Clin Belg; 2015 Jun; 70(3):159-66. PubMed ID: 25495280
    [Abstract] [Full Text] [Related]

  • 9. A Case Series of Obstructive Prosthetic Mitral Valve Thrombosis, Successfully Treated with Low-Dose, Slow Infusion Tissue-Type Plasminogen Activator.
    Ari H, Dogan A, Ceviker K, Aksoy F, Arslan A, Varol E.
    J Heart Valve Dis; 2015 May; 24(3):353-9. PubMed ID: 26901912
    [Abstract] [Full Text] [Related]

  • 10. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events.
    Nagy A, Dénes M, Lengyel M.
    J Heart Valve Dis; 2009 May; 18(3):268-75. PubMed ID: 19557981
    [Abstract] [Full Text] [Related]

  • 11. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
    Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, Oğuz AE, Gündüz S, Astarcioglu MA, Aykan AÇ, Bayram Z, Biteker M, Kaynak E, Kahveci G, Duran NE, Yıldız M.
    Circulation; 2013 Jul 30; 128(5):532-40. PubMed ID: 23812180
    [Abstract] [Full Text] [Related]

  • 12. Thrombolysis or Surgery in Patients With Obstructive Mechanical Valve Thrombosis: The Multicenter HATTUSHA Study.
    Özkan M, Gündüz S, Güner A, Kalçık M, Gürsoy MO, Uygur B, Keleş N, Kaya H, Kılıçgedik A, Bayam E, Kalkan S, Astarcıoğlu MA, Karakoyun S, Yesin M, İnan D, Fedakar A, Sarıkaya S, Aksüt M, Onan B, Koçoğulları CU.
    J Am Coll Cardiol; 2022 Mar 15; 79(10):977-989. PubMed ID: 35272803
    [Abstract] [Full Text] [Related]

  • 13. Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels.
    Farzaneh K, Mortazavi SH, Oraii A, Abbasi K, Salehi Omran A, Ahmadi Tafti SH, Bozorgi A, Kazemi Saeed A, Salarifar M, Sadeghian S.
    J Card Surg; 2020 Oct 15; 35(10):2522-2528. PubMed ID: 33043663
    [Abstract] [Full Text] [Related]

  • 14. Thrombolysis for Left-Sided Prosthetic Valve Thrombosis: Short- and Long-Term Outcomes.
    Gupta S.
    J Heart Valve Dis; 2016 Mar 15; 25(2):214-220. PubMed ID: 27989070
    [Abstract] [Full Text] [Related]

  • 15. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography.
    Ozkan M, Kaymaz C, Kirma C, Sönmez K, Ozdemir N, Balkanay M, Yakut C, Deligönül U.
    J Am Coll Cardiol; 2000 Jun 15; 35(7):1881-9. PubMed ID: 10841239
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Prosthetic Valve Thrombosis with Bolus Dose Tenecteplase: An Experience from a Developing Country.
    Kumar Jha R, Bansal S, S Issar H, Chaudhary M, Sharma S.
    J Heart Valve Dis; 2017 May 15; 26(3):349-354. PubMed ID: 29092122
    [Abstract] [Full Text] [Related]

  • 17. Timing of adverse events during fibrinolytic therapy with streptokinase for left-sided prosthetic valve thrombosis.
    Karthikeyan G, Mathew N, Math RS, Devasenapathy N, Kothari SS, Bahl VK.
    J Thromb Thrombolysis; 2011 Aug 15; 32(2):146-9. PubMed ID: 21416132
    [Abstract] [Full Text] [Related]

  • 18. Successful use of Tenecteplase in a patient with recurrence of prosthetic mitral valve thrombosis.
    Lahoti HA, Goyal BK.
    Indian Heart J; 2015 Dec 15; 67 Suppl 2(Suppl 2):S55-7. PubMed ID: 26688154
    [Abstract] [Full Text] [Related]

  • 19. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis.
    Lengyel M, Vegh G, Vandor L.
    J Heart Valve Dis; 1999 Mar 15; 8(2):167-73. PubMed ID: 10224577
    [Abstract] [Full Text] [Related]

  • 20. Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase.
    Huang F, Lan Y, Cheng Z, Zhang Z, Ren F.
    J Cardiothorac Surg; 2020 Oct 01; 15(1):286. PubMed ID: 33004057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.